Christopher V. Lutman
Providence College(US)Lancaster General Hospital(US)Stony Brook Medicine(US)Women & Infants Hospital of Rhode Island(US)University of Pennsylvania Health System(US)Minnesota Oncology(US)UConn Health(US)
Publications by Year
Research Areas
Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Uterine Myomas and Treatments, Palliative Care and End-of-Life Issues, Cannabis and Cannabinoid Research
Most-Cited Works
- → Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology(2006)205 cited
- → Preoperative identification of patients at risk for delirium after major head and neck cancer surgery(1995)93 cited
- → Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study(2010)74 cited
- → Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations(2007)73 cited
- → Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice(2015)38 cited
- → Use of cannabinoids in cancer patients: A Society of Gynecologic Oncology (SGO) clinical practice statement(2020)